EUVIMEDEUVIMED entdecken
Open Access

Interleukin-1 Receptor Antagonist Gene ( IL1RN ) Variants Modulate the Cytokine Release Syndrome and Mortality of COVID-19

Mukundan Attur iD, Christopher Petrilli, Samrachana Adhikari, Eduardo Iturrate, Xiyue Li, Stephanie Tuminello, Nan Hu, Aravinda Chakravarti, David Beck, Steven B Abramson iD

The Journal of Infectious Diseases · 14.06.2024 · 229 (6) · 1740-1749

DOI: 10.1093/infdis/jiae031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 13.03.2024. Verfasst von Mukundan Attur und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Department of Medicine, New York University Langone Orthopedic Hospital, New York University Langone Health, New York, New …. Hauptthemen laut MEDLINE: Interleukin 1 Receptor Antagonist Protein, COVID-19, Polymorphism, Single Nucleotide, Haplotypes. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIAMS NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

We examined effects of single-nucleotide variants (SNVs) of IL1RN, the gene encoding the anti-inflammatory interleukin 1 receptor antagonist (IL-1Ra), on the cytokine release syndrome (CRS) and mortality in patients with acute severe respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

Methods

IL1RN CTA haplotypes formed from 3 SNVs (rs419598, rs315952, rs9005) and the individual SNVs were assessed for association with laboratory markers of inflammation and mortality. We studied 2589 patients hospitalized with SARS-CoV-2 between March 2020 and March 2021.

Results

Mortality was 15.3% and lower in women than men (13.1% vs 17.3%, P = .0003). Carriers of the CTA-1/2 IL1RN haplotypes exhibited decreased inflammatory markers and increased plasma IL-1Ra. Evaluation of the individual SNVs of the IL1RN, carriers of the rs419598 C/C SNV exhibited significantly reduced inflammatory biomarker levels and numerically lower mortality compared to the C/T-T/T genotype (10.0% vs 17.8%, P = .052) in men, with the most pronounced association observed in male patients ≤74 years old, whose mortality was reduced by 80% (3.1% vs 14.0%, P = .030).

Conclusions

The IL1RN haplotype CTA and C/C variant of rs419598 are associated with attenuation of the CRS and decreased mortality in men with acute SARS-CoV-2 infection. The data suggest that the IL1RN pathway modulates the severity of coronavirus disease 2019 (COVID-19) via endogenous anti-inflammatory mechanisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin 1 Receptor Antagonist ProteinCOVID-19Polymorphism, Single NucleotideHaplotypesSARS-CoV-2Cytokine Release SyndromeHumansMaleFemaleMiddle AgedAgedAdultGenotypeBiomarkers

Stichwörter der Autor:innen

IL1RNSARS-CoV-2genetic variation and mortalityinflammation

Substanzen

Interleukin 1 Receptor Antagonist ProteinIL1RN protein, humanBiomarkers

Autor:innen und Institutionen

  • Division of Rheumatology, Department of Medicine, New York University Langone Orthopedic Hospital, New York University Langone Health, New York, New York, USA.
  • Department of Medicine, New York University Grossman School of Medicine, New York University Langone Health, New York, New York, USA.
  • Division of Biostatistics, Department of Population Health, New York University Grossman School of Medicine, New York, New York, USA.
  • Center for Human Genetics and Genomics, New York University Grossman School of Medicine, New York, New York, USA.

ORCID-Profile: Mukundan Attur, Steven B Abramson

Förderung

  • NCI NIH HHS
  • NIAMS NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Attur, M., Petrilli, C., Adhikari, S., Iturrate, E., Li, X., Tuminello, S., Hu, N., Chakravarti, A., Beck, D., & Abramson, S. B. (2024). Interleukin-1 Receptor Antagonist Gene ( IL1RN ) Variants Modulate the Cytokine Release Syndrome and Mortality of COVID-19. The Journal of Infectious Diseases, 229(6), 1740-1749. https://doi.org/10.1093/infdis/jiae031

Vancouver

Attur M, Petrilli C, Adhikari S, Iturrate E, Li X, Tuminello S, et al. Interleukin-1 Receptor Antagonist Gene ( IL1RN ) Variants Modulate the Cytokine Release Syndrome and Mortality of COVID-19. The Journal of Infectious Diseases. 2024;229(6):1740-1749. doi:10.1093/infdis/jiae031

BibTeX
@article{Attur2024,
  author = {Attur, Mukundan and Petrilli, Christopher and Adhikari, Samrachana and Iturrate, Eduardo and Li, Xiyue and Tuminello, Stephanie and Hu, Nan and Chakravarti, Aravinda and Beck, David and Abramson, Steven B},
  title = {Interleukin-1 Receptor Antagonist Gene ( IL1RN ) Variants Modulate the Cytokine Release Syndrome and Mortality of COVID-19},
  journal = {The Journal of Infectious Diseases},
  year = {2024},
  volume = {229},
  number = {6},
  pages = {1740--1749},
  doi = {10.1093/infdis/jiae031}
}
Kostenlos starten →